ICD1896K ;ALB/JDG - YEARLY DRG UPDATE;8/1/2016
;;18.0;DRG Grouper;**96**;Oct 20, 2000;Build 3
;
; Updates for DRGS 810-999
Q
;
MSDRG ;;MS-DRG^MDC^TYPE^MS-DRG TITLE^WEIGHTS^GEOMETRIC MEAN LOS
;;810^16^MED^MAJOR HEMATOL/IMMUN DIAG EXC SICKLE CELL CRISIS & COAGUL W/O CC/MCC^0.9220^2.6
;;811^16^MED^RED BLOOD CELL DISORDERS W MCC^1.3560^3.7
;;812^16^MED^RED BLOOD CELL DISORDERS W/O MCC^0.8832^2.7
;;813^16^MED^COAGULATION DISORDERS^1.6115^3.7
;;814^16^MED^RETICULOENDOTHELIAL & IMMUNITY DISORDERS W MCC^1.6630^4.5
;;815^16^MED^RETICULOENDOTHELIAL & IMMUNITY DISORDERS W CC^0.9777^3.1
;;816^16^MED^RETICULOENDOTHELIAL & IMMUNITY DISORDERS W/O CC/MCC^0.7216^2.2
;;817^14^SURG^OTHER ANTEPARTUM DIAGNOSES W O.R. PROCEDURE W MCC^2.5317^3.8
;;818^14^SURG^OTHER ANTEPARTUM DIAGNOSES W O.R. PROCEDURE W CC^1.3585^2.8
;;819^14^SURG^OTHER ANTEPARTUM DIAGNOSES W O.R. PROCEDURE W/O CC/MCC^0.8390^1.6
;;820^17^SURG^LYMPHOMA & LEUKEMIA W MAJOR O.R. PROCEDURE W MCC^5.4437^10.9
;;821^17^SURG^LYMPHOMA & LEUKEMIA W MAJOR O.R. PROCEDURE W CC^2.3943^4.3
;;822^17^SURG^LYMPHOMA & LEUKEMIA W MAJOR O.R. PROCEDURE W/O CC/MCC^1.2098^1.9
;;823^17^SURG^LYMPHOMA & NON-ACUTE LEUKEMIA W OTHER PROC W MCC^4.5246^10.4
;;824^17^SURG^LYMPHOMA & NON-ACUTE LEUKEMIA W OTHER PROC W CC^2.1944^5.3
;;825^17^SURG^LYMPHOMA & NON-ACUTE LEUKEMIA W OTHER PROC W/O CC/MCC^1.3590^2.5
;;826^17^SURG^MYELOPROLIF DISORD OR POORLY DIFF NEOPL W MAJ O.R. PROC W MCC^4.9479^9.9
;;827^17^SURG^MYELOPROLIF DISORD OR POORLY DIFF NEOPL W MAJ O.R. PROC W CC^2.2517^4.7
;;828^17^SURG^MYELOPROLIF DISORD OR POORLY DIFF NEOPL W MAJ O.R. PROC W/O CC/MCC^1.6354^3.0
;;829^17^SURG^MYELOPROLIFERATIVE DISORDERS OR POORLY DIFFERENTIATED NEOPLASMS W OTHER PROCEDURE W CC/MCC^3.1097^6.4
;;830^17^SURG^MYELOPROLIFERATIVE DISORDERS OR POORLY DIFFERENTIATED NEOPLASMS W OTHER PROCEDURE W/O CC/MCC^1.4188^2.6
;;831^14^MED^OTHER ANTEPARTUM DIAGNOSES W/O O.R. PROCEDURE W MCC^1.0281^3.2
;;832^14^MED^OTHER ANTEPARTUM DIAGNOSES W/O O.R. PROCEDURE W CC^0.7188^2.5
;;833^14^MED^OTHER ANTEPARTUM DIAGNOSES W/O O.R. PROCEDURE W/O CC/MCC^0.4803^1.9
;;834^17^MED^ACUTE LEUKEMIA W/O MAJOR O.R. PROCEDURE W MCC^5.5078^10.0
;;835^17^MED^ACUTE LEUKEMIA W/O MAJOR O.R. PROCEDURE W CC^2.1360^4.5
;;836^17^MED^ACUTE LEUKEMIA W/O MAJOR O.R. PROCEDURE W/O CC/MCC^1.2126^2.6
;;837^17^MED^CHEMO W ACUTE LEUKEMIA AS SDX OR W HIGH DOSE CHEMO AGENT W MCC^5.3741^12.8
;;838^17^MED^CHEMO W ACUTE LEUKEMIA AS SDX W CC OR HIGH DOSE CHEMO AGENT^2.3526^5.8
;;839^17^MED^CHEMO W ACUTE LEUKEMIA AS SDX W/O CC/MCC^1.2559^4.5
;;840^17^MED^LYMPHOMA & NON-ACUTE LEUKEMIA W MCC^3.2929^7.0
;;841^17^MED^LYMPHOMA & NON-ACUTE LEUKEMIA W CC^1.6348^4.2
;;842^17^MED^LYMPHOMA & NON-ACUTE LEUKEMIA W/O CC/MCC^1.1211^2.9
;;843^17^MED^OTHER MYELOPROLIF DIS OR POORLY DIFF NEOPL DIAG W MCC^1.8460^5.3
;;844^17^MED^OTHER MYELOPROLIF DIS OR POORLY DIFF NEOPL DIAG W CC^1.1788^3.7
;;845^17^MED^OTHER MYELOPROLIF DIS OR POORLY DIFF NEOPL DIAG W/O CC/MCC^0.8662^2.6
;;846^17^MED^CHEMOTHERAPY W/O ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS W MCC^2.8179^6.2
;;847^17^MED^CHEMOTHERAPY W/O ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS W CC^1.3265^3.6
;;848^17^MED^CHEMOTHERAPY W/O ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS W/O CC/MCC^0.9326^2.9
;;849^17^MED^RADIOTHERAPY^1.9702^5.0
;;853^18^SURG^INFECTIOUS & PARASITIC DISEASES W O.R. PROCEDURE W MCC^5.0571^9.9
;;854^18^SURG^INFECTIOUS & PARASITIC DISEASES W O.R. PROCEDURE W CC^2.2028^5.7
;;855^18^SURG^INFECTIOUS & PARASITIC DISEASES W O.R. PROCEDURE W/O CC/MCC^1.5600^3.6
;;856^18^SURG^POSTOPERATIVE OR POST-TRAUMATIC INFECTIONS W O.R. PROC W MCC^4.4883^8.9
;;857^18^SURG^POSTOPERATIVE OR POST-TRAUMATIC INFECTIONS W O.R. PROC W CC^2.0567^5.4
;;858^18^SURG^POSTOPERATIVE OR POST-TRAUMATIC INFECTIONS W O.R. PROC W/O CC/MCC^1.3801^3.7
;;862^18^MED^POSTOPERATIVE & POST-TRAUMATIC INFECTIONS W MCC^1.8277^5.0
;;863^18^MED^POSTOPERATIVE & POST-TRAUMATIC INFECTIONS W/O MCC^0.9848^3.5
;;864^18^MED^FEVER AND INFLAMMATORY CONDITIONS^0.8643^2.8
;;865^18^MED^VIRAL ILLNESS W MCC^1.3822^3.9
;;866^18^MED^VIRAL ILLNESS W/O MCC^0.8204^2.7
;;867^18^MED^OTHER INFECTIOUS & PARASITIC DISEASES DIAGNOSES W MCC^2.1329^5.6
;;868^18^MED^OTHER INFECTIOUS & PARASITIC DISEASES DIAGNOSES W CC^1.0769^3.6
;;869^18^MED^OTHER INFECTIOUS & PARASITIC DISEASES DIAGNOSES W/O CC/MCC^0.7679^2.7
;;870^18^MED^SEPTICEMIA OR SEVERE SEPSIS W MV >96 HOURS OR PERIPHERAL EXTRACORPOREAL MEMBRANE OXYGENATION (ECMO)^6.2953^12.4
;;871^18^MED^SEPTICEMIA OR SEVERE SEPSIS W/O MV >96 HOURS W MCC^1.8564^4.8
;;872^18^MED^SEPTICEMIA OR SEVERE SEPSIS W/O MV >96 HOURS W/O MCC^1.0529^3.7
;;876^19^SURG^O.R. PROCEDURE W PRINCIPAL DIAGNOSES OF MENTAL ILLNESS^3.3014^7.2
;;880^19^MED^ACUTE ADJUSTMENT REACTION & PSYCHOSOCIAL DYSFUNCTION^0.8111^2.6
;;881^19^MED^DEPRESSIVE NEUROSES^0.7585^3.8
;;882^19^MED^NEUROSES EXCEPT DEPRESSIVE^0.7750^3.2
;;883^19^MED^DISORDERS OF PERSONALITY & IMPULSE CONTROL^1.3199^4.8
;;884^19^MED^ORGANIC DISTURBANCES & INTELLECTUAL DISABILITY^1.3479^4.3
;;885^19^MED^PSYCHOSES^1.1961^5.8
;;886^19^MED^BEHAVIORAL & DEVELOPMENTAL DISORDERS^0.9887^3.7
;;887^19^MED^OTHER MENTAL DISORDER DIAGNOSES^1.0645^3.0
;;894^20^MED^ALCOHOL/DRUG ABUSE OR DEPENDENCE, LEFT AMA^0.5169^2.1
;;895^20^MED^ALCOHOL/DRUG ABUSE OR DEPENDENCE W REHABILITATION THERAPY^1.4328^8.6
;;896^20^MED^ALCOHOL/DRUG ABUSE OR DEPENDENCE W/O REHABILITATION THERAPY W MCC^1.7468^4.9
;;897^20^MED^ALCOHOL/DRUG ABUSE OR DEPENDENCE W/O REHABILITATION THERAPY W/O MCC^0.8208^3.4
;;901^21^SURG^WOUND DEBRIDEMENTS FOR INJURIES W MCC^4.4649^9.2
;;902^21^SURG^WOUND DEBRIDEMENTS FOR INJURIES W CC^1.9204^4.9
;;903^21^SURG^WOUND DEBRIDEMENTS FOR INJURIES W/O CC/MCC^1.1639^2.9
;;904^21^SURG^SKIN GRAFTS FOR INJURIES W CC/MCC^3.2260^6.7
;;905^21^SURG^SKIN GRAFTS FOR INJURIES W/O CC/MCC^1.7692^3.5
;;906^21^SURG^HAND PROCEDURES FOR INJURIES^1.8432^2.8
;;907^21^SURG^OTHER O.R. PROCEDURES FOR INJURIES W MCC^4.2161^7.2
;;908^21^SURG^OTHER O.R. PROCEDURES FOR INJURIES W CC^1.9928^4.0
;;909^21^SURG^OTHER O.R. PROCEDURES FOR INJURIES W/O CC/MCC^1.3254^2.5
;;913^21^MED^TRAUMATIC INJURY W MCC^1.4719^3.6
;;914^21^MED^TRAUMATIC INJURY W/O MCC^0.8378^2.5
;;915^21^MED^ALLERGIC REACTIONS W MCC^1.6769^3.7
;;916^21^MED^ALLERGIC REACTIONS W/O MCC^0.6353^1.8
;;917^21^MED^POISONING & TOXIC EFFECTS OF DRUGS W MCC^1.4737^3.5
;;918^21^MED^POISONING & TOXIC EFFECTS OF DRUGS W/O MCC^0.7787^2.3
;;919^21^MED^COMPLICATIONS OF TREATMENT W MCC^1.8243^4.3
;;920^21^MED^COMPLICATIONS OF TREATMENT W CC^1.0031^2.9
;;921^21^MED^COMPLICATIONS OF TREATMENT W/O CC/MCC^0.7066^2.2
;;922^21^MED^OTHER INJURY, POISONING & TOXIC EFFECT DIAG W MCC^1.5584^3.8
;;923^21^MED^OTHER INJURY, POISONING & TOXIC EFFECT DIAG W/O MCC^0.8698^2.7
;;927^22^SURG^EXTENSIVE BURNS OR FULL THICKNESS BURNS W MV >96 HRS W SKIN GRAFT^18.3845^22.2
;;928^22^SURG^FULL THICKNESS BURN W SKIN GRAFT OR INHAL INJ W CC/MCC^5.8756^10.7
;;929^22^SURG^FULL THICKNESS BURN W SKIN GRAFT OR INHAL INJ W/O CC/MCC^2.9722^5.8
;;933^22^MED^EXTENSIVE BURNS OR FULL THICKNESS BURNS W MV >96 HRS W/O SKIN GRAFT^2.8603^2.6
;;934^22^MED^FULL THICKNESS BURN W/O SKIN GRAFT OR INHAL INJ^1.8335^4.2
;;935^22^MED^NON-EXTENSIVE BURNS^1.8217^3.4
;;939^23^SURG^O.R. PROC W DIAGNOSES OF OTHER CONTACT W HEALTH SERVICES W MCC^3.2787^6.5
;;940^23^SURG^O.R. PROC W DIAGNOSES OF OTHER CONTACT W HEALTH SERVICES W CC^2.1745^3.7
;;941^23^SURG^O.R. PROC W DIAGNOSES OF OTHER CONTACT W HEALTH SERVICES W/O CC/MCC^1.8514^2.3
;;945^23^MED^REHABILITATION W CC/MCC^1.3649^9.4
;;946^23^MED^REHABILITATION W/O CC/MCC^1.0427^7.1
;;947^23^MED^SIGNS & SYMPTOMS W MCC^1.2056^3.5
;;948^23^MED^SIGNS & SYMPTOMS W/O MCC^0.7802^2.6
;;949^23^MED^AFTERCARE W CC/MCC^1.1462^4.5
;;950^23^MED^AFTERCARE W/O CC/MCC^0.7449^3.4
;;951^23^MED^OTHER FACTORS INFLUENCING HEALTH STATUS^0.7984^2.5
;;955^24^SURG^CRANIOTOMY FOR MULTIPLE SIGNIFICANT TRAUMA^6.0969^7.4
;;956^24^SURG^LIMB REATTACHMENT, HIP & FEMUR PROC FOR MULTIPLE SIGNIFICANT TRAUMA^3.7838^6.1
;;957^24^SURG^OTHER O.R. PROCEDURES FOR MULTIPLE SIGNIFICANT TRAUMA W MCC^7.5985^9.7
;;958^24^SURG^OTHER O.R. PROCEDURES FOR MULTIPLE SIGNIFICANT TRAUMA W CC^4.1798^7.0
;;959^24^SURG^OTHER O.R. PROCEDURES FOR MULTIPLE SIGNIFICANT TRAUMA W/O CC/MCC^2.4507^3.8
;;963^24^MED^OTHER MULTIPLE SIGNIFICANT TRAUMA W MCC^2.7950^5.3
;;964^24^MED^OTHER MULTIPLE SIGNIFICANT TRAUMA W CC^1.4749^4.0
;;965^24^MED^OTHER MULTIPLE SIGNIFICANT TRAUMA W/O CC/MCC^0.9743^2.7
;;969^25^SURG^HIV W EXTENSIVE O.R. PROCEDURE W MCC^5.5987^11.7
;;970^25^SURG^HIV W EXTENSIVE O.R. PROCEDURE W/O MCC^2.7877^6.5
;;974^25^MED^HIV W MAJOR RELATED CONDITION W MCC^2.7230^6.4
;;975^25^MED^HIV W MAJOR RELATED CONDITION W CC^1.2899^4.1
;;976^25^MED^HIV W MAJOR RELATED CONDITION W/O CC/MCC^0.9386^3.1
;;977^25^MED^HIV W OR W/O OTHER RELATED CONDITION^1.1699^3.4
;;981^99^SURG^EXTENSIVE O.R. PROCEDURE UNRELATED TO PRINCIPAL DIAGNOSIS W MCC^4.3705^8.4
;;982^99^SURG^EXTENSIVE O.R. PROCEDURE UNRELATED TO PRINCIPAL DIAGNOSIS W CC^2.4529^4.9
;;983^99^SURG^EXTENSIVE O.R. PROCEDURE UNRELATED TO PRINCIPAL DIAGNOSIS W/O CC/MCC^1.5691^2.5
;;987^99^SURG^NON-EXTENSIVE O.R. PROC UNRELATED TO PRINCIPAL DIAGNOSIS W MCC^3.3326^8.1
;;988^99^SURG^NON-EXTENSIVE O.R. PROC UNRELATED TO PRINCIPAL DIAGNOSIS W CC^1.6931^4.4
;;989^99^SURG^NON-EXTENSIVE O.R. PROC UNRELATED TO PRINCIPAL DIAGNOSIS W/O CC/MCC^1.0407^2.1
;;998^99^**^PRINCIPAL DIAGNOSIS INVALID AS DISCHARGE DIAGNOSIS^0.00^0.00
;;999^99^**^UNGROUPABLE^0.00^0.00
;;EXIT
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HICD1896K 9640 printed Dec 13, 2024@01:49:45 Page 2
ICD1896K ;ALB/JDG - YEARLY DRG UPDATE;8/1/2016
+1 ;;18.0;DRG Grouper;**96**;Oct 20, 2000;Build 3
+2 ;
+3 ; Updates for DRGS 810-999
+4 QUIT
+5 ;
MSDRG ;;MS-DRG^MDC^TYPE^MS-DRG TITLE^WEIGHTS^GEOMETRIC MEAN LOS
+1 ;;810^16^MED^MAJOR HEMATOL/IMMUN DIAG EXC SICKLE CELL CRISIS & COAGUL W/O CC/MCC^0.9220^2.6
+2 ;;811^16^MED^RED BLOOD CELL DISORDERS W MCC^1.3560^3.7
+3 ;;812^16^MED^RED BLOOD CELL DISORDERS W/O MCC^0.8832^2.7
+4 ;;813^16^MED^COAGULATION DISORDERS^1.6115^3.7
+5 ;;814^16^MED^RETICULOENDOTHELIAL & IMMUNITY DISORDERS W MCC^1.6630^4.5
+6 ;;815^16^MED^RETICULOENDOTHELIAL & IMMUNITY DISORDERS W CC^0.9777^3.1
+7 ;;816^16^MED^RETICULOENDOTHELIAL & IMMUNITY DISORDERS W/O CC/MCC^0.7216^2.2
+8 ;;817^14^SURG^OTHER ANTEPARTUM DIAGNOSES W O.R. PROCEDURE W MCC^2.5317^3.8
+9 ;;818^14^SURG^OTHER ANTEPARTUM DIAGNOSES W O.R. PROCEDURE W CC^1.3585^2.8
+10 ;;819^14^SURG^OTHER ANTEPARTUM DIAGNOSES W O.R. PROCEDURE W/O CC/MCC^0.8390^1.6
+11 ;;820^17^SURG^LYMPHOMA & LEUKEMIA W MAJOR O.R. PROCEDURE W MCC^5.4437^10.9
+12 ;;821^17^SURG^LYMPHOMA & LEUKEMIA W MAJOR O.R. PROCEDURE W CC^2.3943^4.3
+13 ;;822^17^SURG^LYMPHOMA & LEUKEMIA W MAJOR O.R. PROCEDURE W/O CC/MCC^1.2098^1.9
+14 ;;823^17^SURG^LYMPHOMA & NON-ACUTE LEUKEMIA W OTHER PROC W MCC^4.5246^10.4
+15 ;;824^17^SURG^LYMPHOMA & NON-ACUTE LEUKEMIA W OTHER PROC W CC^2.1944^5.3
+16 ;;825^17^SURG^LYMPHOMA & NON-ACUTE LEUKEMIA W OTHER PROC W/O CC/MCC^1.3590^2.5
+17 ;;826^17^SURG^MYELOPROLIF DISORD OR POORLY DIFF NEOPL W MAJ O.R. PROC W MCC^4.9479^9.9
+18 ;;827^17^SURG^MYELOPROLIF DISORD OR POORLY DIFF NEOPL W MAJ O.R. PROC W CC^2.2517^4.7
+19 ;;828^17^SURG^MYELOPROLIF DISORD OR POORLY DIFF NEOPL W MAJ O.R. PROC W/O CC/MCC^1.6354^3.0
+20 ;;829^17^SURG^MYELOPROLIFERATIVE DISORDERS OR POORLY DIFFERENTIATED NEOPLASMS W OTHER PROCEDURE W CC/MCC^3.1097^6.4
+21 ;;830^17^SURG^MYELOPROLIFERATIVE DISORDERS OR POORLY DIFFERENTIATED NEOPLASMS W OTHER PROCEDURE W/O CC/MCC^1.4188^2.6
+22 ;;831^14^MED^OTHER ANTEPARTUM DIAGNOSES W/O O.R. PROCEDURE W MCC^1.0281^3.2
+23 ;;832^14^MED^OTHER ANTEPARTUM DIAGNOSES W/O O.R. PROCEDURE W CC^0.7188^2.5
+24 ;;833^14^MED^OTHER ANTEPARTUM DIAGNOSES W/O O.R. PROCEDURE W/O CC/MCC^0.4803^1.9
+25 ;;834^17^MED^ACUTE LEUKEMIA W/O MAJOR O.R. PROCEDURE W MCC^5.5078^10.0
+26 ;;835^17^MED^ACUTE LEUKEMIA W/O MAJOR O.R. PROCEDURE W CC^2.1360^4.5
+27 ;;836^17^MED^ACUTE LEUKEMIA W/O MAJOR O.R. PROCEDURE W/O CC/MCC^1.2126^2.6
+28 ;;837^17^MED^CHEMO W ACUTE LEUKEMIA AS SDX OR W HIGH DOSE CHEMO AGENT W MCC^5.3741^12.8
+29 ;;838^17^MED^CHEMO W ACUTE LEUKEMIA AS SDX W CC OR HIGH DOSE CHEMO AGENT^2.3526^5.8
+30 ;;839^17^MED^CHEMO W ACUTE LEUKEMIA AS SDX W/O CC/MCC^1.2559^4.5
+31 ;;840^17^MED^LYMPHOMA & NON-ACUTE LEUKEMIA W MCC^3.2929^7.0
+32 ;;841^17^MED^LYMPHOMA & NON-ACUTE LEUKEMIA W CC^1.6348^4.2
+33 ;;842^17^MED^LYMPHOMA & NON-ACUTE LEUKEMIA W/O CC/MCC^1.1211^2.9
+34 ;;843^17^MED^OTHER MYELOPROLIF DIS OR POORLY DIFF NEOPL DIAG W MCC^1.8460^5.3
+35 ;;844^17^MED^OTHER MYELOPROLIF DIS OR POORLY DIFF NEOPL DIAG W CC^1.1788^3.7
+36 ;;845^17^MED^OTHER MYELOPROLIF DIS OR POORLY DIFF NEOPL DIAG W/O CC/MCC^0.8662^2.6
+37 ;;846^17^MED^CHEMOTHERAPY W/O ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS W MCC^2.8179^6.2
+38 ;;847^17^MED^CHEMOTHERAPY W/O ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS W CC^1.3265^3.6
+39 ;;848^17^MED^CHEMOTHERAPY W/O ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS W/O CC/MCC^0.9326^2.9
+40 ;;849^17^MED^RADIOTHERAPY^1.9702^5.0
+41 ;;853^18^SURG^INFECTIOUS & PARASITIC DISEASES W O.R. PROCEDURE W MCC^5.0571^9.9
+42 ;;854^18^SURG^INFECTIOUS & PARASITIC DISEASES W O.R. PROCEDURE W CC^2.2028^5.7
+43 ;;855^18^SURG^INFECTIOUS & PARASITIC DISEASES W O.R. PROCEDURE W/O CC/MCC^1.5600^3.6
+44 ;;856^18^SURG^POSTOPERATIVE OR POST-TRAUMATIC INFECTIONS W O.R. PROC W MCC^4.4883^8.9
+45 ;;857^18^SURG^POSTOPERATIVE OR POST-TRAUMATIC INFECTIONS W O.R. PROC W CC^2.0567^5.4
+46 ;;858^18^SURG^POSTOPERATIVE OR POST-TRAUMATIC INFECTIONS W O.R. PROC W/O CC/MCC^1.3801^3.7
+47 ;;862^18^MED^POSTOPERATIVE & POST-TRAUMATIC INFECTIONS W MCC^1.8277^5.0
+48 ;;863^18^MED^POSTOPERATIVE & POST-TRAUMATIC INFECTIONS W/O MCC^0.9848^3.5
+49 ;;864^18^MED^FEVER AND INFLAMMATORY CONDITIONS^0.8643^2.8
+50 ;;865^18^MED^VIRAL ILLNESS W MCC^1.3822^3.9
+51 ;;866^18^MED^VIRAL ILLNESS W/O MCC^0.8204^2.7
+52 ;;867^18^MED^OTHER INFECTIOUS & PARASITIC DISEASES DIAGNOSES W MCC^2.1329^5.6
+53 ;;868^18^MED^OTHER INFECTIOUS & PARASITIC DISEASES DIAGNOSES W CC^1.0769^3.6
+54 ;;869^18^MED^OTHER INFECTIOUS & PARASITIC DISEASES DIAGNOSES W/O CC/MCC^0.7679^2.7
+55 ;;870^18^MED^SEPTICEMIA OR SEVERE SEPSIS W MV >96 HOURS OR PERIPHERAL EXTRACORPOREAL MEMBRANE OXYGENATION (ECMO)^6.2953^12.4
+56 ;;871^18^MED^SEPTICEMIA OR SEVERE SEPSIS W/O MV >96 HOURS W MCC^1.8564^4.8
+57 ;;872^18^MED^SEPTICEMIA OR SEVERE SEPSIS W/O MV >96 HOURS W/O MCC^1.0529^3.7
+58 ;;876^19^SURG^O.R. PROCEDURE W PRINCIPAL DIAGNOSES OF MENTAL ILLNESS^3.3014^7.2
+59 ;;880^19^MED^ACUTE ADJUSTMENT REACTION & PSYCHOSOCIAL DYSFUNCTION^0.8111^2.6
+60 ;;881^19^MED^DEPRESSIVE NEUROSES^0.7585^3.8
+61 ;;882^19^MED^NEUROSES EXCEPT DEPRESSIVE^0.7750^3.2
+62 ;;883^19^MED^DISORDERS OF PERSONALITY & IMPULSE CONTROL^1.3199^4.8
+63 ;;884^19^MED^ORGANIC DISTURBANCES & INTELLECTUAL DISABILITY^1.3479^4.3
+64 ;;885^19^MED^PSYCHOSES^1.1961^5.8
+65 ;;886^19^MED^BEHAVIORAL & DEVELOPMENTAL DISORDERS^0.9887^3.7
+66 ;;887^19^MED^OTHER MENTAL DISORDER DIAGNOSES^1.0645^3.0
+67 ;;894^20^MED^ALCOHOL/DRUG ABUSE OR DEPENDENCE, LEFT AMA^0.5169^2.1
+68 ;;895^20^MED^ALCOHOL/DRUG ABUSE OR DEPENDENCE W REHABILITATION THERAPY^1.4328^8.6
+69 ;;896^20^MED^ALCOHOL/DRUG ABUSE OR DEPENDENCE W/O REHABILITATION THERAPY W MCC^1.7468^4.9
+70 ;;897^20^MED^ALCOHOL/DRUG ABUSE OR DEPENDENCE W/O REHABILITATION THERAPY W/O MCC^0.8208^3.4
+71 ;;901^21^SURG^WOUND DEBRIDEMENTS FOR INJURIES W MCC^4.4649^9.2
+72 ;;902^21^SURG^WOUND DEBRIDEMENTS FOR INJURIES W CC^1.9204^4.9
+73 ;;903^21^SURG^WOUND DEBRIDEMENTS FOR INJURIES W/O CC/MCC^1.1639^2.9
+74 ;;904^21^SURG^SKIN GRAFTS FOR INJURIES W CC/MCC^3.2260^6.7
+75 ;;905^21^SURG^SKIN GRAFTS FOR INJURIES W/O CC/MCC^1.7692^3.5
+76 ;;906^21^SURG^HAND PROCEDURES FOR INJURIES^1.8432^2.8
+77 ;;907^21^SURG^OTHER O.R. PROCEDURES FOR INJURIES W MCC^4.2161^7.2
+78 ;;908^21^SURG^OTHER O.R. PROCEDURES FOR INJURIES W CC^1.9928^4.0
+79 ;;909^21^SURG^OTHER O.R. PROCEDURES FOR INJURIES W/O CC/MCC^1.3254^2.5
+80 ;;913^21^MED^TRAUMATIC INJURY W MCC^1.4719^3.6
+81 ;;914^21^MED^TRAUMATIC INJURY W/O MCC^0.8378^2.5
+82 ;;915^21^MED^ALLERGIC REACTIONS W MCC^1.6769^3.7
+83 ;;916^21^MED^ALLERGIC REACTIONS W/O MCC^0.6353^1.8
+84 ;;917^21^MED^POISONING & TOXIC EFFECTS OF DRUGS W MCC^1.4737^3.5
+85 ;;918^21^MED^POISONING & TOXIC EFFECTS OF DRUGS W/O MCC^0.7787^2.3
+86 ;;919^21^MED^COMPLICATIONS OF TREATMENT W MCC^1.8243^4.3
+87 ;;920^21^MED^COMPLICATIONS OF TREATMENT W CC^1.0031^2.9
+88 ;;921^21^MED^COMPLICATIONS OF TREATMENT W/O CC/MCC^0.7066^2.2
+89 ;;922^21^MED^OTHER INJURY, POISONING & TOXIC EFFECT DIAG W MCC^1.5584^3.8
+90 ;;923^21^MED^OTHER INJURY, POISONING & TOXIC EFFECT DIAG W/O MCC^0.8698^2.7
+91 ;;927^22^SURG^EXTENSIVE BURNS OR FULL THICKNESS BURNS W MV >96 HRS W SKIN GRAFT^18.3845^22.2
+92 ;;928^22^SURG^FULL THICKNESS BURN W SKIN GRAFT OR INHAL INJ W CC/MCC^5.8756^10.7
+93 ;;929^22^SURG^FULL THICKNESS BURN W SKIN GRAFT OR INHAL INJ W/O CC/MCC^2.9722^5.8
+94 ;;933^22^MED^EXTENSIVE BURNS OR FULL THICKNESS BURNS W MV >96 HRS W/O SKIN GRAFT^2.8603^2.6
+95 ;;934^22^MED^FULL THICKNESS BURN W/O SKIN GRAFT OR INHAL INJ^1.8335^4.2
+96 ;;935^22^MED^NON-EXTENSIVE BURNS^1.8217^3.4
+97 ;;939^23^SURG^O.R. PROC W DIAGNOSES OF OTHER CONTACT W HEALTH SERVICES W MCC^3.2787^6.5
+98 ;;940^23^SURG^O.R. PROC W DIAGNOSES OF OTHER CONTACT W HEALTH SERVICES W CC^2.1745^3.7
+99 ;;941^23^SURG^O.R. PROC W DIAGNOSES OF OTHER CONTACT W HEALTH SERVICES W/O CC/MCC^1.8514^2.3
+100 ;;945^23^MED^REHABILITATION W CC/MCC^1.3649^9.4
+101 ;;946^23^MED^REHABILITATION W/O CC/MCC^1.0427^7.1
+102 ;;947^23^MED^SIGNS & SYMPTOMS W MCC^1.2056^3.5
+103 ;;948^23^MED^SIGNS & SYMPTOMS W/O MCC^0.7802^2.6
+104 ;;949^23^MED^AFTERCARE W CC/MCC^1.1462^4.5
+105 ;;950^23^MED^AFTERCARE W/O CC/MCC^0.7449^3.4
+106 ;;951^23^MED^OTHER FACTORS INFLUENCING HEALTH STATUS^0.7984^2.5
+107 ;;955^24^SURG^CRANIOTOMY FOR MULTIPLE SIGNIFICANT TRAUMA^6.0969^7.4
+108 ;;956^24^SURG^LIMB REATTACHMENT, HIP & FEMUR PROC FOR MULTIPLE SIGNIFICANT TRAUMA^3.7838^6.1
+109 ;;957^24^SURG^OTHER O.R. PROCEDURES FOR MULTIPLE SIGNIFICANT TRAUMA W MCC^7.5985^9.7
+110 ;;958^24^SURG^OTHER O.R. PROCEDURES FOR MULTIPLE SIGNIFICANT TRAUMA W CC^4.1798^7.0
+111 ;;959^24^SURG^OTHER O.R. PROCEDURES FOR MULTIPLE SIGNIFICANT TRAUMA W/O CC/MCC^2.4507^3.8
+112 ;;963^24^MED^OTHER MULTIPLE SIGNIFICANT TRAUMA W MCC^2.7950^5.3
+113 ;;964^24^MED^OTHER MULTIPLE SIGNIFICANT TRAUMA W CC^1.4749^4.0
+114 ;;965^24^MED^OTHER MULTIPLE SIGNIFICANT TRAUMA W/O CC/MCC^0.9743^2.7
+115 ;;969^25^SURG^HIV W EXTENSIVE O.R. PROCEDURE W MCC^5.5987^11.7
+116 ;;970^25^SURG^HIV W EXTENSIVE O.R. PROCEDURE W/O MCC^2.7877^6.5
+117 ;;974^25^MED^HIV W MAJOR RELATED CONDITION W MCC^2.7230^6.4
+118 ;;975^25^MED^HIV W MAJOR RELATED CONDITION W CC^1.2899^4.1
+119 ;;976^25^MED^HIV W MAJOR RELATED CONDITION W/O CC/MCC^0.9386^3.1
+120 ;;977^25^MED^HIV W OR W/O OTHER RELATED CONDITION^1.1699^3.4
+121 ;;981^99^SURG^EXTENSIVE O.R. PROCEDURE UNRELATED TO PRINCIPAL DIAGNOSIS W MCC^4.3705^8.4
+122 ;;982^99^SURG^EXTENSIVE O.R. PROCEDURE UNRELATED TO PRINCIPAL DIAGNOSIS W CC^2.4529^4.9
+123 ;;983^99^SURG^EXTENSIVE O.R. PROCEDURE UNRELATED TO PRINCIPAL DIAGNOSIS W/O CC/MCC^1.5691^2.5
+124 ;;987^99^SURG^NON-EXTENSIVE O.R. PROC UNRELATED TO PRINCIPAL DIAGNOSIS W MCC^3.3326^8.1
+125 ;;988^99^SURG^NON-EXTENSIVE O.R. PROC UNRELATED TO PRINCIPAL DIAGNOSIS W CC^1.6931^4.4
+126 ;;989^99^SURG^NON-EXTENSIVE O.R. PROC UNRELATED TO PRINCIPAL DIAGNOSIS W/O CC/MCC^1.0407^2.1
+127 ;;998^99^**^PRINCIPAL DIAGNOSIS INVALID AS DISCHARGE DIAGNOSIS^0.00^0.00
+128 ;;999^99^**^UNGROUPABLE^0.00^0.00
+129 ;;EXIT